The home of the Audio Journal of Oncology
Andreas Gille

Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes

AudioMedica News
AudioMedica News
Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes
Loading
/
Andreas Gille
Andreas Gille

LOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having another, according to conclusions from a phase I study released at the 2012 American Heart Association annual sessions in Los Angeles. Sarah Maxwell heard from Andreas Gille, Head of Clinical and Translational Science Strategy at the company CSL Ltd in Melbourne, Australia, about their findings from healthy volunteers receiving CSL 112 — a form of human apo-lipoprotein A1 purified from human plasma and reconstituted with phospholipid to yield HDL particles suitable for I/V infusion.



LISTEN

[audio:https://www.audiomedica.com/podcasting/aha/121115AndreasGillePODCASTLoRes.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality